Side-by-side financials for AYTU and AZN. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | AYTU | AZN |
|---|---|---|
| Market cap | - | $286.27 B |
| US-listed rank | - | #45 |
| Revenue (latest FY) | $66.38M | - |
| Net income (latest FY) | -$13.56M | - |
| Net margin | -20.4% | - |
| SEC filings | 893 | 1,004 |
Full pages: AYTU BIOPHARMA, INC and AstraZeneca PLC, or browse the full rankings.